191 related articles for article (PubMed ID: 18364124)
41. Vascular density in childhood acute lymphoblastic leukaemia correlates to biological factors and outcome.
Norén-Nyström U; Heyman M; Frisk P; Golovleva I; Sundström C; Porwit A; Roos G; Bergh A; Forestier E
Br J Haematol; 2009 Sep; 146(5):521-30. PubMed ID: 19594745
[TBL] [Abstract][Full Text] [Related]
42. Treatment of children with acute lymphoblastic leukemia in India using a BFM protocol.
Bajel A; George B; Mathews V; Viswabandya A; Kavitha ML; Srivastava A; Chandy M
Pediatr Blood Cancer; 2008 Nov; 51(5):621-5. PubMed ID: 18688848
[TBL] [Abstract][Full Text] [Related]
43. Acute lymphoblastic leukemia in adolescents and young adults in Finland.
Usvasalo A; Räty R; Knuutila S; Vettenranta K; Harila-Saari A; Jantunen E; Kauppila M; Koistinen P; Parto K; Riikonen P; Salmi TT; Silvennoinen R; Elonen E; Saarinen-Pihkala UM
Haematologica; 2008 Aug; 93(8):1161-8. PubMed ID: 18556413
[TBL] [Abstract][Full Text] [Related]
44. Re: "Detecting small-area similarities in the epidemiology of childhood acute lymphoblastic leukemia and diabetes mellitus, type 1: a Bayesian approach".
Richiardi L; Magnani C; Bruno G; Maule MM; Merletti F; Pastore G
Am J Epidemiol; 2005 Dec; 162(11):1132-3. PubMed ID: 16221801
[No Abstract] [Full Text] [Related]
45. Late effects in long-term survivors after treatment for childhood acute leukemia.
Haddy TB; Mosher RB; Reaman GH
Clin Pediatr (Phila); 2009 Jul; 48(6):601-8. PubMed ID: 19264722
[TBL] [Abstract][Full Text] [Related]
46. A retrospective evaluation of infant patients with acute lymphoblastic leukemia treated at a single institution.
Luciani M; Cimino G; Angioni A; Russo LA; Sprovieri T; De Rossi G
Haematologica; 1999 May; 84(5):464-5. PubMed ID: 10329928
[No Abstract] [Full Text] [Related]
47. Clinical trials referral resource. Current clinical trials in pediatric acute lymphoblastic leukemia.
Smith M; Newsome SY; Cheson BD
Oncology (Williston Park); 2000 Dec; 14(12):1720, 1723-5. PubMed ID: 11204374
[No Abstract] [Full Text] [Related]
48. Management of pregnancy in adolescence complicated by acute lymphoblastic leukemia.
Papantoniou N; Daskalakis G; Marinopoulos S; Anastasakis E; Mesogitis S; Antsaklis A
Fetal Diagn Ther; 2008; 23(2):164-7. PubMed ID: 18046077
[TBL] [Abstract][Full Text] [Related]
49. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.
Bader P; Kreyenberg H; Henze GH; Eckert C; Reising M; Willasch A; Barth A; Borkhardt A; Peters C; Handgretinger R; Sykora KW; Holter W; Kabisch H; Klingebiel T; von Stackelberg A;
J Clin Oncol; 2009 Jan; 27(3):377-84. PubMed ID: 19064980
[TBL] [Abstract][Full Text] [Related]
50. [Clinical importance of minimal residual disease testing in the therapy of childhood B-cell acute lymphoblastic leukemia].
Ye QD; Gu LJ; Tang JY; Xue HL; Chen J; Pan C; Chen J; Dong L; Zhou M; Jiang LM
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Jun; 10(3):333-6. PubMed ID: 18554462
[TBL] [Abstract][Full Text] [Related]
51. Skeletal morbidity in childhood acute lymphoblastic leukaemia.
Davies JH; Evans BA; Jenney ME; Gregory JW
Clin Endocrinol (Oxf); 2005 Jul; 63(1):1-9. PubMed ID: 15963054
[No Abstract] [Full Text] [Related]
52. Toward a total cure for acute lymphoblastic leukemia.
Pui CH
J Clin Oncol; 2009 Nov; 27(31):5121-3. PubMed ID: 19805663
[No Abstract] [Full Text] [Related]
53. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract][Full Text] [Related]
54. Intrathecal chemoprophylaxis after HSCT in children.
Rubin J; Frost BM; Arvidson J; Wide K; Gustafsson-Jernberg A; Gustafsson B
Pediatr Transplant; 2008 Dec; 12(8):889-95. PubMed ID: 18822104
[TBL] [Abstract][Full Text] [Related]
55. Early morbidity and mortality in childhood acute lymphoblastic leukemia with very high white blood cell count.
Vaitkeviciene G; Heyman M; Jonsson OG; Lausen B; Harila-Saari A; Stenmarker M; Taskinen M; Zvirblis T; Åsberg A; Groth-Pedersen L; Rageliene L; Schmiegelow K
Leukemia; 2013 Nov; 27(11):2259-62. PubMed ID: 23689480
[No Abstract] [Full Text] [Related]
56. New decision support tool for treatment intensity choice in childhood acute lymphoblastic leukemia.
Pedreira CE; Macrini L; Land MG; Costa ES
IEEE Trans Inf Technol Biomed; 2009 May; 13(3):284-90. PubMed ID: 19423428
[TBL] [Abstract][Full Text] [Related]
57. Long-term follow-up of children treated for acute lymphoblastic leukemia and the recovery of beta-cell function.
Mohn A; Di Marzio D; De Berardiniis A; Di Marzio A; Capanna R; Fioritoni G; Chiarelli F
Haematologica; 2006 Oct; 91(10):1424-5. PubMed ID: 16963397
[TBL] [Abstract][Full Text] [Related]
58. Management of brain abscesses in children treated for acute lymphoblastic leukemia.
Lackner H; Sovinz P; Benesch M; Smolle-Jüttner F; Mokry M; Schwinger W; Moser A; Urban C
Pediatr Blood Cancer; 2009 Mar; 52(3):408-11. PubMed ID: 18989879
[TBL] [Abstract][Full Text] [Related]
59. Childhood and adolescent lymphoblastic lymphoma: end of the beginning and future directions.
Hochberg J; Cairo MS
Pediatr Blood Cancer; 2009 Dec; 53(6):917-9. PubMed ID: 19672977
[No Abstract] [Full Text] [Related]
60. [Leukemia treatment results have improved, but prognosis is still questionable].
Siimes MA
Duodecim; 1997; 113(7):677-82. PubMed ID: 11466897
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
